Imagin Medical to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

World News: . []

VANCOUVER, British Columbia and BOSTON, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that management will present an update on the Company’s business at the first annual on Tuesday, December 10, 2019 at 12:00 p.m. Eastern Time.

The presentation will be broadcast live and archived on the Company's website at under "Events & Presentations.”

Imagin Medical is a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive surgeries. The Company believes its first product, the i/Blue™ Imaging System, will dramatically improve surgeons’ ability to visualize cancerous cells by producing higher-quality images more quickly compared with current methods. Based on advanced optics and light sensors, the i/Blue Imaging System employs patented ultrasensitive imaging technology and offers easy-to-use viewing options for more accurate resection. The Company’s initial focus is bladder cancer. Learn more at .

Stephen Kilmer, Investor Relations Telephone: 647-872-4849Email:

Jim Hutchens, President & CEO Telephone: 833-246-2446

More news and information about Imagin Medical Inc.

Published By:

Globe Newswire: 13:00 GMT Tuesday 3rd December 2019

Published: .

Search for other references to "imagin" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us